Medical Properties (MPW) Shareholder Warning: Johnson Fistula

Medical Properties (MPW) Shareholder Warning: Johnson Fistula

Facebook
Twitter
LinkedIn

SAN DIEGO, Oct. 06, 2022 (GLOBE NEWSWIRE) – Shareholder Rights Law Firm Johnson Fistel, LLP (www.JohnsonFistula.com) examines whether Medical Properties Trust Inc (NYSE:MPW), one of its officers or others has violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The focus of the investigation is on investors’ losses and whether they can be recovered under federal securities laws.

What if I bought Medical Properties Trust common stock? If you have purchased Medical Properties Trust common stock and have suffered significant losses on your investment, join our investigation now:

There are no costs or obligations for you.

What does Johnson examine fistula? On October 6, 2022, The Bear Cave published a report entitled “Further Troubles at Medical Properties Trust (MPW)”. The Bear Cave report claims that it “uncovers a random assortment of problems, including distressed tenants, dubious representations, overspending, potential problems with auditor independence, and a confusing undisclosed property management entity.”

What if I have relevant non-public information? Those with nonpublic information about the company should consider cooperating with our investigation or participating in the SEC’s whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to 30% for each successful recovery by the SEC. For more information, contact Jim Baker at (619) 814-4471 or [email protected].

Contact:
Johnson Fistula, LLP
Jim Baker, Senior Securities Analyst
Phone: (619) 814-4471
E-mail: [email protected]

Continue to read on GlobeNewswire https://www.globenewswire.com/news-release/2022/10/06/2529771/0/en/Medical-Properties-MPW-Shareholder-Alert-Johnson-Fistel-Encourages-Medical-Properties-Shareholders-with-Losses-to-Contact-the-Firm-Regarding-Investigation.html

More to explorer